Kirsten Gillibrand said...
Mandating the coverage of abuse deterrent opioids is a flawed approach and the FDA acknowledges that these products are not abuse proof.
Context
Gillibrand criticizes mandatory coverage of abuse deterrent opioids.
02/26/2018